The Role of the Amylin Analogue Cagrilintide in Bone Metabolism

NCT07010432 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Cagrilintide
DRUG: Semaglutide
DRUG: Placebo cagrilintide
DRUG: Placebo semaglutide

Sponsor

Novo Nordisk A/S